Cleveland Heights Chiropractic And Rehabilitation Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3084 Mayfield Rd, Cleveland Heights, OH 44118 Phone: 216-321-7246 |
Dr. Christopher C Sonich, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2905 Mayfield Rd, Cleveland Heights, OH 44118 Phone: 216-371-3680 Fax: 216-371-3627 |
Cleveland Chiropractic & Wellness Center, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 2460 Fairmount Blvd, Unit B, Cleveland Heights, OH 44106 Phone: 216-231-5783 |
Taylor Chiropractic And Therapy Center Chiropractor Medicare: Medicare Enrolled Practice Location: 2179 S Taylor Rd, Cleveland Heights, OH 44118 Phone: 216-371-6200 Fax: 216-371-1410 |
Emily L. Arnold, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 2460 Fairmount Blvd, Unit B, Cleveland Heights, OH 44106 Phone: 216-231-5783 Fax: 216-231-5907 |
Dr. Michael John Ibach, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5 Severance Cir Ste 702, Cleveland Heights, OH 44118 Phone: 216-291-9400 Fax: 216-291-9401 |
Severance Chiropractic Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3084 Mayfield Rd, Cleveland Heights, OH 44118 Phone: 216-321-7246 Fax: 440-937-2239 |
News Archive
SCIENTISTS at the University of Huddersfield are the first to arrive at a deep understanding of a molecule that destroys cancerous tumours without harming healthy cell tissue.
Dyax Corp. and CMIC Co., Ltd, announced today an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE) and other angioedema indications in Japan.
More than half of the states that applied to participate in a controversial CMS pilot for dual-eligible beneficiaries have either dropped out or delayed implementation of their programs, according to health policy experts. Among the 26 states that applied to participate in the CMS Financial Alignment Initiative, which stems from the Patient Protection and Affordable Care Act, six have dropped out or opted for different "customized" plans and nine have delayed their start dates (Daly, 5/23).
Gen-Probe Incorporated announced today that it has received a European CE mark for its APTIMA® assay for Trichomonas vaginalis, a common parasitic sexually transmitted disease.
› Verified 2 days ago